Skip to main content

SK Capital buys two more

SK Capital Partners has made two further acquisitions in May, buying SK Capital Partners from Miami-based investment firm HIG Capital in a deal that is expected to close in Q3 subject to customary closing conditions, and Florachem from an affiliate of Carmelina Capital. Terms were not disclosed in either deal.

Valtris, which is headquartered in Independence, Ohio, has nine manufacturing facilities worldwide. It makes speciality additives and chemicals that impart including flexibility, stability, processability and flame retardance to plastics and other materials.

Valtris to change hands

Miami-based HIG Capital alternative investment firm HIG Capital has agreed to sell Valtris Specialty Chemicals to an affiliate of funds managed by SK Capital Partners. The transaction is expected to close in Q3, subject to customary closing conditions. Terms were not disclosed.

Valtris is located in Independence, Ohio, and operates nine manufacturing facilities worldwide. It makes speciality polymer additives to impart flexibility, stability processability and flame retardance, plus speciality chemicals for a wide range of end markets.

Clariant completes Pigments exit

Clariant has completed the previously announced sale of most of its Pigments business to Heubach Group and SK Capital Partners, completing its transformation into a speciality chemicals firm. The business has about 3,000 employees and revenues of €1 billion/year.

The deal gives Pigments a base enterprise value of CHF 805 million, subject to closing accounts adjustments and before a potential earn-out payment of CHF 50 million depending on its financial performance in 2021. Clariant has retained a 20% stake in the new holding company. in order to profit from its future growth

Seqens confirms changed ownership

CDMO Seqens has confirmed that its planned change of ownership has been completed, with SK Capital, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, becoming the majority shareholder.

Seqens takeover confirmed

SK Capital Partners has announced that it, Eurazeo and other shareholders in Seqens have entered a formal agreement for it to acquire Seqens. This follows a period of exclusive negotiations and the agreement of the employee representative body. This remains subject to regulatory approval. S

Change of owner at Seqens?

Eurazeo has announced that it has entered into exclusive discussions to sell its stake in French-based CDMO Seqens to funds advised by SK Capital Partners and its existing French shareholders, Mérieux Equity Partners.

Seqens commented that SK Capital’s involvement could enhance its position in the production of APIs, pharmaceutical intermediates and speciality ingredients. SK has already owned API manufacturer Wavelength Pharmaceuticals since 2017.

Pigments divestment completes Clariant sales

Clariant has agreed to sell 80% of its Pigments business to a consortium made up of German pigments specialist Heubach Group and private investment firm SK Capital Partners, which owns many other chemical industry operations. This should close in 1H 2022.

Subscribe to SK Capital